Overview

Radiopharmaceutical Market is forecasted to value over CAGR of 4.2% from the forecast period 2022-2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Radiopharmaceutical Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Radiopharmaceutical Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Radiopharmaceutical Market are    

• GE Healthcare
• Antheus Medical Imaging, Inc.
• Mallinckrodt
• Siemens Healthineers
• Advanced Accelerator Application
• Bayer AG
• Eckert & Ziegler
• IBA Radiopharma Solutions
• Philips
• Jubilant Life Sciences Limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

Radiopharmaceutical Market Segmentation:

By Source

• Nuclear Reactors
• Cyclotrons

By Radioisotope

• Technetium-99
• Gallium-67
• Iodine-123
• Iodine-125
• 18F
• Rubidium-82
• Yttrium-90
• Lutetium-177
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers
• Cancer Research Institutes
• Others

By Type

• PET/CT
• SPECT
• Therapeutics

By Application

• Gastro-intestinal
• Oncology
• Nephrology
• Cardiology
• Neurology
• Inflammation
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share  
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Radiopharmaceutical Market by source, by radioisotope, by end user, by type, by application and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization services offered are free of charge with purchase of any license of the report.
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
          1.1. Objectives of the Study 
          1.2. Market Definition 
          1.3. Market Scope 
                 1.3.1. Years Considered for the Study
                 1.3.2. Market Covered
          1.4. Currency 
          1.5. Limitations 
          1.6. Stakeholders 
 2.  Research Methodology 
          2.1. Research Data 
                 2.1.1. Secondary Data
                          2.1.1.1. Key Data from Secondary Sources
                 2.1.2. Primary Data
                          2.1.2.1. Key Data from Primary Sources
          2.2. Market Size Estimation 
          2.3. Market Breakdown and Data Triangulation 
          2.4. Assumptions for the Study  
3. Executive Summary
          3.1. Market Outlook
          3.2. Segment Outlook
          3.3. Competitive Insights
4. Global Radiopharmaceutical Market Variables, Trends & Scope
          4.1. Market Lineage Outlook
          4.2. Penetration and Growth Prospect Mapping
          4.3. Industry Value Chain Analysis
          4.4. Cost Analysis Breakdown
          4.5. Technology Overview
          4.6. Regulatory Framework
                 4.6.1. Reimbursement Framework
                 4.6.2. Standards and Compliances
5. Global Radiopharmaceutical Market Overview
          5.1. Market Dynamics
                  5.1.1. Market Driver Analysis
                            5.1.1.1. Increasing focus on Brand Protection
                            5.1.1.2. Untapped Opportunities in Emerging Regions
                  5.1.2. Market Restraint Analysis
                  5.1.3. Industry Challenges
                            5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Radiopharmaceutical Market Analysis Tools
          6.1. Industry Analysis - Porter’s
                  6.1.1. Supplier Power
                  6.1.2. Buyer Power
                  6.1.3. Substitution Threat
                  6.1.4. Threat from New Entrants
                  6.1.5. Competitive Rivalry
          6.2. Pestel Analysis
                  6.2.1. Political Landscape
                  6.2.2. Environmental Landscape
                  6.2.3. Social Landscape
                  6.2.4. Technology Landscape
                  6.2.5. Legal Landscape
          6.3. Major Deals And Strategic Alliances Analysis
                  6.3.1. Joint Ventures
                  6.3.2. Mergers and Acquisitions
                  6.3.3. Licensing and Partnership
                  6.3.4. Technology Collaborations
                  6.3.5. Strategic Divestments
          6.4. Market Entry Strategies
          6.5. Case Studies
7. Global Radiopharmaceutical Market, By Source Historical Analysis and Forecast 2022-2028 (USD Million)
           7.1. Nuclear Reactors
           7.2. Cyclotrons
8. Global Radiopharmaceutical Market, By Radioisotope Historical Analysis and Forecast 2022-2028 (USD Million)                              
           8.1. Technetium-99
           8.2. Gallium-67
           8.3. Iodine-123
           8.4. Iodine-125
           8.5. 18F
           8.6. Rubidium-82
           8.7. Yttrium-90
           8.8. Lutetium-177
           8.9. Others
9. Global Radiopharmaceutical Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
           9.1. Hospitals
           9.2. Ambulatory Surgical Centers
           9.3. Diagnostic Centers
           9.4. Cancer Research Institutes
           9.5. Others
10. Global Radiopharmaceutical Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million)
           10.1 PET/CT
           10.2 SPECT
           10.3 Therapeutics
11. Global Radiopharmaceutical Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
           11.1. Gastro-intestinal
           11.2. Oncology
                     11.2.1. Brachytherapy
                     11.2.2. Others
           11.3. Nephrology
           11.4. Cardiology
           11.5. Neurology
           11.6. Inflammation
           11.7. Others
12.  North America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           12.1. Introduction
           12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     12.2.1. U.S.A
                     12.2.2. Canada
                     12.2.3. Mexico
           12.3. Market Size (USD Million) Forecast for North America 2022-2028
13. Latin America Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           13.1. Introduction
           13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     13.2.1. Brazil
                     13.2.2. Venezuela
                     13.2.3. Argentina
                     13.2.4. Rest of Latin America
           13.3. Market Size (USD Million) Forecast for Latin America 2022-2028
14. Europe Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           14.1. Introduction
           14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     14.2.1. Germany
                     14.2.2. U.K
                     14.2.3. France
                     14.2.4. Italy
                     14.2.5. Spain
                     14.2.6. Russia
                     14.2.7. Poland
                     14.2.8. Switzerland
                     14.2.9. Rest of Western Europe
15. Asia Pacific Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           15.1. Introduction
           15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     15.2.1. Japan
                     15.2.2. China
                     15.2.3. Singapore
                     15.2.4. India
                     15.2.5. Australia and New Zealand
                     15.2.6. ASEAN
                     15.2.7. South Korea
                     15.2.8. Rest of Asia Pacific
           15.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
16. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million)
           16.1. Introduction
           16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
                     16.2.1. GCC
                     16.2.2. Israel
                     16.2.3. South Africa
                     16.2.4. Rest of MEA
           16.3. Market Size (USD Million) Forecast for MEA 2022-2028           
17. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts)
           17.1. GE Healthcare
                     17.1.1. Company Overview
                     17.1.2. Product Portfolio
                     17.1.3. SWOT Analysis
                     17.1.4. Financial Overview
                     17.1.5. Strategic Overview
           17.2. Antheus Medical Imaging, Inc.
                     17.2.1. Company Overview
                     17.2.2. Product Portfolio
                     17.2.3. SWOT Analysis
                     17.2.4. Financial Overview
                     17.2.5. Strategic Overview
           17.3. Mallinckrodt
                     17.3.1. Company Overview
                     17.3.2. Product Portfolio
                     17.3.3. SWOT Analysis
                     17.3.4. Financial Overview
                     17.3.5. Strategic Overview
           17.4. Siemens Healthineers
                     17.4.1. Company Overview
                     17.4.2. Product Portfolio
                     17.4.3. SWOT Analysis
                     17.4.4. Financial Overview
                     17.4.5. Strategic Overview
           17.5. Advanced Accelerator Application
                     17.5.1. Company Overview
                     17.5.2. Product Portfolio
                     17.5.3. SWOT Analysis
                     17.5.4. Financial Overview
                     17.5.5. Strategic Overview
           17.6. Bayer AG
                     17.6.1. Company Overview
                     17.6.2. Product Portfolio
                     17.6.3.  SWOT Analysis
                     17.6.4. Financial Overview
                     17.6.5. Strategic Overview
           17.7. Eckert & Ziegler
                     17.7.1. Company Overview
                     17.7.2. Product Portfolio
                     17.7.3. SWOT Analysis
                     17.7.4. Financial Overview
                     17.7.5. Strategic Overview
           17.8. IBA Radiopharma Solutions
                     17.8.1. Company Overview
                     17.8.2. Product Portfolio
                     17.8.3. SWOT Analysis
                     17.8.4. Financial Overview
                     17.8.5. Strategic Overview
           17.9. Philips
                      17.9.1. Company Overview
                      17.9.2. Product Portfolio
                      17.9.3. SWOT Analysis
                      17.9.4. Financial Overview
                      17.9.5. Strategic Overview
           17.10. Jubilant Life Sciences Limited
                      17.10.1. Company Overview
                      17.10.2. Product Portfolio
                      17.10.3. SWOT Analysis
                      17.10.4. Financial Overview
                      17.10.5. Strategic Overview
18. Pre and Post COVID-19 Impact
    18.1. Positive influence on the healthcare industry
    18.2. The financial disruption of the manufacturing sector
    18.3. Impact of COVID-19 on emerging companies
    18.4. Significant mandates in the healthcare regulations initiated by administrations
    18.5. The overall economic slowdown of the developing and developed nations
19. FutureWise SME key takeaway points for Client

Tables

Figures